Impairment of memory function by antihypertensive medication

Archives of General Psychiatry
S SolomonR S Blum


This study describes a specific memory impairment in subjects taking either of two kinds of centrally active anti-hypertensive agents. Verbal memory impairment was present in hypertensive and normotensive patients taking methyldopa or propranolol hydrochloride, while hypertensive patients receiving only a diuretic did not show this deficit. Visual memory impairment was not seen in any of the groups tested. The majority of the subjects were unaware of their memory deficit, even when test results clearly revealed impairment. An earlier pilot study of 12 hypertensive patients receiving methyldopa or propranolol used a broad range of cognitive tests and also demonstrated impairment in verbal memory only, while other cognitive measures remained relatively unaffected.


Sep 2, 2006·Neurological Research·Christine Bergmann, Mary Sano
Nov 24, 1999·Clinical Therapeutics·L M NelsenL E Markson
Sep 1, 1994·British Journal of Clinical Pharmacology·D G McDevittM B Zetlein
Feb 1, 1994·British Journal of Clinical Pharmacology·L KalraS H Jackson
Feb 1, 1993·British Journal of Clinical Pharmacology·J PowellT Goggin
Feb 28, 2007·Vascular Health and Risk Management·J Tisaire-SánchezAngel Navarro
Mar 3, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Ihab HajjarPaul Eleazer
Dec 1, 1990·Journal of Clinical Pharmacology·B JohnsonJ Johnson
Jan 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·G FinaliG L Piccinin
Jan 1, 1991·Progress in Neuro-psychopharmacology & Biological Psychiatry·B F JohnsonJ Johnson
Dec 6, 2001·Current Hypertension Reports·J P RoelR H Grimm
Dec 31, 1993·Behavioural Brain Research·C Mondadori
Jan 1, 1997·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Z GuoB Winblad
Jul 15, 2004·Psychopharmacology·Britta Hahn, Ian P Stolerman
Jan 1, 1993·European Journal of Clinical Pharmacology·L GerrardD G McDevitt
Jan 1, 1987·Physiology & Behavior·L Gonder-FrederickP E Gold
Jan 1, 1990·Pharmacology & Therapeutics·J McAinsh, J M Cruickshank
Oct 1, 1984·Psychosomatics·R M Swift, H R Black
Mar 2, 2010·Disease-a-month : DM·Antonio CherubiniUmberto Senin
Oct 15, 2013·Journal of the American Geriatrics Society·Basil M RuDusky
Sep 1, 1985·Behavioral and Neural Biology·D B SternbergJ L McGaugh
Jan 1, 1987·Journal of Chronic Diseases·A E FletcherC J Bulpitt
Mar 1, 1991·The American Journal of Medicine·K O'MalleyE O'Brien
Aug 1, 1988·British Journal of Clinical Pharmacology·D CurrieN A Wright
Jun 1, 1986·British Journal of Clinical Pharmacology·I LichterM A Wyke
Jan 1, 1986·British Journal of Clinical Pharmacology·A E Fletcher, C J Bulpitt
Jan 1, 1988·Neuroscience and Biobehavioral Reviews·J S Turkkan
Jan 29, 1988·The American Journal of Medicine·C J Bulpitt, A E Fletcher
Apr 1, 1996·Journal of the American Geriatrics Society·J M StarrI J Deary
Apr 7, 2004·Cell·Charles F MurchisonSteven A Thomas
Jan 1, 1991·International Journal of Psychiatry in Medicine·S L RauchR M Zusman
Jan 23, 1989·The American Journal of Medicine·M H Weinberger
Oct 1, 1995·Experimental Aging Research·M F MuldoonJ R Jennings
Jun 17, 2004·Journal of Basic and Clinical Physiology and Pharmacology·Jan J BraszkoPaul R Gard
Sep 1, 2016·BMC Cardiovascular Disorders·María J González-MoneoJosep Comín-Colet
Mar 1, 1990·Neuropsychology Review·H E King, R E Miller
Jan 1, 1991·European Journal of Clinical Pharmacology·A E FletcherC J Bulpitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.